Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5732-5737, October 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guzman, R. C.
Right arrow Articles by Nandi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guzman, R. C.
Right arrow Articles by Nandi, S.

Incidence of c-Ki-ras Activation in N-Methyl-N-nitrosourea-induced Mammary Carcinomas in Pituitary-isografted Mice1

Raphael C. Guzman2, Rebecca C. Osborn, Steven M. Swanson, Ramasamy Sakthivel, Soo-In Hwang, Shigeki Miyamoto3 and Satyabrata Nandi

Cancer Research Laboratory, Department of Molecular and Cell Biology, University of California, Berkeley, California 94720

We found previously that mouse mammary epithelial cells cultured in the presence of the mammogenic hormones progesterone and prolactin and treated with the carcinogen N-methyl-N-nitrosourea produced a high frequency of hyperplastic alveolar nodules and carcinomas with squamous metaplasia upon transplantation to syngeneic mice. The majority of these mammary transformants had an activated c-Ki-ras protooncogene with a specific point mutation in codon 12 (G35 to A35). To determine whether these in vitro findings parallel mammary carcinogenesis in vivo, virgin female mice were pituitary isografted to increase their circulating levels of progesterone and prolactin. The pituitary isograft results in an increase in proliferation, leading to lobulo-alveolar development and differentiation of the mammary epithelial cells. Five weeks after pituitary isografting, the mice were treated with a single injection of N-methyl-N-nitrosourea (50 µg/g body weight). Greater than 90% of the N-methyl-N-nitrosourea-treated mice developed mammary carcinomas between 3 and 7 months after treatment. The majority (75%) of the carcinomas had histopathology identical to that of tumors induced in vitro in the presence of progesterone and prolactin. A number of the mammary cancers (17%) induced in pituitary-isografted mice also had the identical point mutation in the c-Ki-ras proto-oncogene found in the in vitro studies. These results suggest that the hormonal milieu around the time of carcinogen exposure affects not only the incidence and phenotype of the mammary transformants but also the molecular events associated with mammary carcinogenesis.

1 This research was supported by Grants CA-05388 and CA-09041 awarded by the NIH, Department of Health and Human Services, and Grant 1-523865-36647 from the University of California Cancer Research Coordinating Committee.

2 To whom requests for reprints should be addressed, at Cancer Research Laboratory, Room 491, Life Sciences Addition, University of California, Berkeley, CA 94720.

3 Present address: Molecular Biology and Virology Laboratory, The Salk Institute, La Jolla, CA 92037.

Received 5/ 1/92. Accepted 8/ 8/92.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. W. Jang, R. B. Boxer, and L. A. Chodosh
Isoform-Specific Ras Activation and Oncogene Dependence during MYC- and Wnt-Induced Mammary Tumorigenesis
Mol. Cell. Biol., November 1, 2006; 26(21): 8109 - 8121.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. V. Maffini, A. M. Soto, J. M. Calabro, A. A. Ucci, and C. Sonnenschein
The stroma as a crucial target in rat mammary gland carcinogenesis
J. Cell Sci., March 15, 2004; 117(8): 1495 - 1502.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Weinberg, M.-M. Rivera, R. Prell, A. Morris, T. Ramstad, J. T. Vetto, W. J. Urba, G. Alvord, C. Bunce, and J. Shields
Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity
J. Immunol., February 15, 2000; 164(4): 2160 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. P. Lydon, G. Ge, F. S. Kittrell, D. Medina, and B. W. O'Malley
Murine Mammary Gland Carcinogenesis Is Critically Dependent on Progesterone Receptor Function
Cancer Res., September 1, 1999; 59(17): 4276 - 4284.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. Hurwitz, T. F.-Y. Yu, D. R. Leach, and J. P. Allison
CTLA-4 blockade synergizes with tumor-derived granulocyte- macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
PNAS, August 18, 1998; 95(17): 10067 - 10071.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Engelbergs, J. Thomale, A. Galhoff, and M. F. Rajewsky
Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea
PNAS, February 17, 1998; 95(4): 1635 - 1640.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.